Search - tctmd.com

Displaying 21 - 40 of 106

Sort: Relevancy | Date

Presentation TCT 2019

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Presenter: Yoshimitsu Soga

September 26, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Conference News TCT 2019

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Yael L. Maxwell

September 25, 2019

Presentation TCT 2019

Updates and Technique of Percutaneous Transvenous Arterial Femoral Popliteal Bypass Procedure

Presenter: Steve Henao

September 25, 2019

Presentation TCT 2019

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

Is the Supera Interwoven Stent Better Than Other Stents and Open Endarterectomy for Common Femoral Lesions?

Presenter: Lawrence Garcia

September 25, 2019

Presentation TCT 2019

Can Baseline IVUS Predict Dissection Patterns of Femoropopliteal Lesions?

Presenter: Daizo Kawasaki

September 25, 2019

Presentation TCT 2019

Common Femoral CTO: Knives, Needles, or Both?

Presenter: Bryan Fisher

September 25, 2019

News Daily News

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Yael L. Maxwell

August 29, 2019

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Caitlin E. Cox

August 15, 2019

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Caitlin E. Cox

August 12, 2019

News Daily News

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Todd Neale

August 07, 2019

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

Presentation CHIP Seattle 2019

Complications and Management of Femoral Access

Presenter: Curtiss T. Stinis

August 02, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

Advertisement

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Updates and Technique of Percutaneous Transvenous Arterial Femoral Popliteal Bypass Procedure

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Is the Supera Interwoven Stent Better Than Other Stents and Open Endarterectomy for Common Femoral Lesions?

Can Baseline IVUS Predict Dissection Patterns of Femoropopliteal Lesions?

Common Femoral CTO: Knives, Needles, or Both?

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Complications and Management of Femoral Access

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Microvascular Disease Quadruples Risk of Leg Amputation

TCTMD’s Top 10 Most Popular Stories for June 2019

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content